Skip to content
LaidLaw Capital Markets Logo
  • Capital Markets
  • Capital Markets Team
  • Equity Research
    • Research Coverage List
  • Case Studies
  • Contact Us
  • Back to Laidlaw & Company
Previous
Immuni 175_40

By admin|2016-08-10T04:03:10-04:00August 10th, 2016|Comments Off on Immuni 175_40

Share This Story, Choose Your Platform!

FacebookTwitterRedditLinkedInTumblrPinterestVkEmail

Site Info

Home
Contact Us

Legal

Terms & Conditions
Legal Information
Privacy Policy
Glossary Record of Processing Activities
GDPR Rights Exercise Form

Disclosures

FINRA
SIPC
FCA
Business Continuity Plan Disclosure
SEC Order Routing Disclosure
Brokercheck

Copyright 2020 Laidlaw & Company (UK) Ltd. - All Rights Reserved. Laidlaw & Company (UK) Ltd., a FINRA broker-dealer registered in the United States, clears on a fully-disclosed basis through INTL FCStone Financial Inc., a member of the Securities Investor Protection Corporation (SIPC). Laidlaw & Company International Limited is authorized and regulated by the Financial Conduct Authority (FCA) in the UK (Firm Reference No: 537165).
Toggle Sliding Bar Area
  • Research Coverage List
  • Research Overview
Go to Top